Cargando…
Biomarkers in biological fluids for dementia with Lewy bodies
Dementia with Lewy bodies (DLB) has become the second most common neurodegenerative dementia due to demographic ageing. Differential diagnosis is still troublesome especially in early stages of the disease, since there is a great clinical and neuropathological overlap primarily with Alzheimer’s dise...
Autores principales: | Schade, Sebastian, Mollenhauer, Brit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255553/ https://www.ncbi.nlm.nih.gov/pubmed/25478030 http://dx.doi.org/10.1186/s13195-014-0072-3 |
Ejemplares similares
-
Cerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies
por: Mukaetova-Ladinska, Elizabeta B., et al.
Publicado: (2010) -
Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies
por: Foska, Aikaterini, et al.
Publicado: (2022) -
Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014) -
Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies
por: van de Beek, M., et al.
Publicado: (2020) -
Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium
por: Scott, Gregory D., et al.
Publicado: (2022)